Used in pharmaceutical research as a key intermediate in the development of kinase inhibitors, particularly targeting receptor tyrosine kinases involved in cancer cell proliferation. Shows potential in anti-tumor agents due to its ability to modulate signaling pathways in malignant cells. Also investigated for anti-inflammatory applications owing to its structural affinity with bioactive benzimidazole derivatives. Employed in structure-activity relationship (SAR) studies to optimize drug candidates for improved selectivity and metabolic stability.